PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC: Topic: Medical Oncology

PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC: Topic: Medical Oncology

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thoracic oncology 2016-11, Vol.11 (11), p.S307-S308
Hauptverfasser: Rybkin, Igor I., Smit, Egbert, Kopp, Hans-Georg, Kim, Dong-Wan, Spira, Alexander, Berruti, Alfredo, Lee, Dae Ho, Reguart, Noemí, Akimov, Mikhail, Schumacher, Karl, Upalawanna, Allison, Squires, Matthew, Tan, Daniel S.-W.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S308
container_issue 11
container_start_page S307
container_title Journal of thoracic oncology
container_volume 11
creator Rybkin, Igor I.
Smit, Egbert
Kopp, Hans-Georg
Kim, Dong-Wan
Spira, Alexander
Berruti, Alfredo
Lee, Dae Ho
Reguart, Noemí
Akimov, Mikhail
Schumacher, Karl
Upalawanna, Allison
Squires, Matthew
Tan, Daniel S.-W.
description
doi_str_mv 10.1016/j.jtho.2016.09.095
format Article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmed_primary_27969527</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1556086416310449</els_id><sourcerecordid>S1556086416310449</sourcerecordid><originalsourceid>FETCH-LOGICAL-e767-4bc3ab6d6753019317cbe32a01ca0fa32d5cd1713cceca394cd10c554bf95e423</originalsourceid><addsrcrecordid>eNo1Udtq3DAQFaWlSdP-QB_KvHftSJZlr5e-BLNJTXeTJfG7kKVxV4tv2NpN81mFfkG-LDJJ4cCcYQ6HmTmEfGU0ZJQll4fw4PZ9GHke0sxDvCPnTIgkYHxJ379xukziM_Jpmg6UxoLGy4_kLEqzJBNRek7-7R4oCxO6gt0eiuqyKBZQjlY10NdQ3ObRksLzX1iPTe9sZys4TbBrlOfHFr7DDlt0I_5BA7aDK3NsHAxugkfr9rC-ub4PtkenHJoF6O26BNUOja3t3M9TKH8VcI-TnZzq3MIbnFSnvdntQ77JV1D2g9Ur2KKx2q901-m-6X8_fSYfatVM-OWtXpDyel3mP4PN3U2RX20CTJM0iCvNVZWYJBWcsoyzVFfII0WZVrRWPDJCG5YyrjVqxbPYd1QLEVd1JjCO-AX59mo7HKsWjRxG26rxSf7_nhf8eBWgX-JkcZSTtjgfYEfUTpreSkblHJY8yDksOYclaeYh-As5o4So</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC: Topic: Medical Oncology</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rybkin, Igor I. ; Smit, Egbert ; Kopp, Hans-Georg ; Kim, Dong-Wan ; Spira, Alexander ; Berruti, Alfredo ; Lee, Dae Ho ; Reguart, Noemí ; Akimov, Mikhail ; Schumacher, Karl ; Upalawanna, Allison ; Squires, Matthew ; Tan, Daniel S.-W.</creator><creatorcontrib>Rybkin, Igor I. ; Smit, Egbert ; Kopp, Hans-Georg ; Kim, Dong-Wan ; Spira, Alexander ; Berruti, Alfredo ; Lee, Dae Ho ; Reguart, Noemí ; Akimov, Mikhail ; Schumacher, Karl ; Upalawanna, Allison ; Squires, Matthew ; Tan, Daniel S.-W.</creatorcontrib><identifier>ISSN: 1556-0864</identifier><identifier>EISSN: 1556-1380</identifier><identifier>DOI: 10.1016/j.jtho.2016.09.095</identifier><identifier>PMID: 27969527</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><ispartof>Journal of thoracic oncology, 2016-11, Vol.11 (11), p.S307-S308</ispartof><rights>2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27969527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rybkin, Igor I.</creatorcontrib><creatorcontrib>Smit, Egbert</creatorcontrib><creatorcontrib>Kopp, Hans-Georg</creatorcontrib><creatorcontrib>Kim, Dong-Wan</creatorcontrib><creatorcontrib>Spira, Alexander</creatorcontrib><creatorcontrib>Berruti, Alfredo</creatorcontrib><creatorcontrib>Lee, Dae Ho</creatorcontrib><creatorcontrib>Reguart, Noemí</creatorcontrib><creatorcontrib>Akimov, Mikhail</creatorcontrib><creatorcontrib>Schumacher, Karl</creatorcontrib><creatorcontrib>Upalawanna, Allison</creatorcontrib><creatorcontrib>Squires, Matthew</creatorcontrib><creatorcontrib>Tan, Daniel S.-W.</creatorcontrib><title>PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC: Topic: Medical Oncology</title><title>Journal of thoracic oncology</title><addtitle>J Thorac Oncol</addtitle><issn>1556-0864</issn><issn>1556-1380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNo1Udtq3DAQFaWlSdP-QB_KvHftSJZlr5e-BLNJTXeTJfG7kKVxV4tv2NpN81mFfkG-LDJJ4cCcYQ6HmTmEfGU0ZJQll4fw4PZ9GHke0sxDvCPnTIgkYHxJ379xukziM_Jpmg6UxoLGy4_kLEqzJBNRek7-7R4oCxO6gt0eiuqyKBZQjlY10NdQ3ObRksLzX1iPTe9sZys4TbBrlOfHFr7DDlt0I_5BA7aDK3NsHAxugkfr9rC-ub4PtkenHJoF6O26BNUOja3t3M9TKH8VcI-TnZzq3MIbnFSnvdntQ77JV1D2g9Ur2KKx2q901-m-6X8_fSYfatVM-OWtXpDyel3mP4PN3U2RX20CTJM0iCvNVZWYJBWcsoyzVFfII0WZVrRWPDJCG5YyrjVqxbPYd1QLEVd1JjCO-AX59mo7HKsWjRxG26rxSf7_nhf8eBWgX-JkcZSTtjgfYEfUTpreSkblHJY8yDksOYclaeYh-As5o4So</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Rybkin, Igor I.</creator><creator>Smit, Egbert</creator><creator>Kopp, Hans-Georg</creator><creator>Kim, Dong-Wan</creator><creator>Spira, Alexander</creator><creator>Berruti, Alfredo</creator><creator>Lee, Dae Ho</creator><creator>Reguart, Noemí</creator><creator>Akimov, Mikhail</creator><creator>Schumacher, Karl</creator><creator>Upalawanna, Allison</creator><creator>Squires, Matthew</creator><creator>Tan, Daniel S.-W.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope></search><sort><creationdate>201611</creationdate><title>PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC: Topic: Medical Oncology</title><author>Rybkin, Igor I. ; Smit, Egbert ; Kopp, Hans-Georg ; Kim, Dong-Wan ; Spira, Alexander ; Berruti, Alfredo ; Lee, Dae Ho ; Reguart, Noemí ; Akimov, Mikhail ; Schumacher, Karl ; Upalawanna, Allison ; Squires, Matthew ; Tan, Daniel S.-W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e767-4bc3ab6d6753019317cbe32a01ca0fa32d5cd1713cceca394cd10c554bf95e423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rybkin, Igor I.</creatorcontrib><creatorcontrib>Smit, Egbert</creatorcontrib><creatorcontrib>Kopp, Hans-Georg</creatorcontrib><creatorcontrib>Kim, Dong-Wan</creatorcontrib><creatorcontrib>Spira, Alexander</creatorcontrib><creatorcontrib>Berruti, Alfredo</creatorcontrib><creatorcontrib>Lee, Dae Ho</creatorcontrib><creatorcontrib>Reguart, Noemí</creatorcontrib><creatorcontrib>Akimov, Mikhail</creatorcontrib><creatorcontrib>Schumacher, Karl</creatorcontrib><creatorcontrib>Upalawanna, Allison</creatorcontrib><creatorcontrib>Squires, Matthew</creatorcontrib><creatorcontrib>Tan, Daniel S.-W.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><jtitle>Journal of thoracic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rybkin, Igor I.</au><au>Smit, Egbert</au><au>Kopp, Hans-Georg</au><au>Kim, Dong-Wan</au><au>Spira, Alexander</au><au>Berruti, Alfredo</au><au>Lee, Dae Ho</au><au>Reguart, Noemí</au><au>Akimov, Mikhail</au><au>Schumacher, Karl</au><au>Upalawanna, Allison</au><au>Squires, Matthew</au><au>Tan, Daniel S.-W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC: Topic: Medical Oncology</atitle><jtitle>Journal of thoracic oncology</jtitle><addtitle>J Thorac Oncol</addtitle><date>2016-11</date><risdate>2016</risdate><volume>11</volume><issue>11</issue><spage>S307</spage><epage>S308</epage><pages>S307-S308</pages><issn>1556-0864</issn><eissn>1556-1380</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27969527</pmid><doi>10.1016/j.jtho.2016.09.095</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1556-0864
ispartof Journal of thoracic oncology, 2016-11, Vol.11 (11), p.S307-S308
issn 1556-0864
1556-1380
language eng
recordid cdi_pubmed_primary_27969527
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title PS01.60: Ph Ib/II, Trial of INC280 ± Erlotinib vs Platinum + Pemetrexed in Adult pts with EGFR-Mutated, cMET amplified, EGFR TKI Resistant, Advanced NSCLC: Topic: Medical Oncology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T03%3A04%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PS01.60:%20Ph%20Ib/II,%20Trial%20of%20INC280%20%C2%B1%20Erlotinib%20vs%20Platinum%20+%20Pemetrexed%20in%20Adult%20pts%20with%20EGFR-Mutated,%20cMET%20amplified,%20EGFR%20TKI%20Resistant,%20Advanced%20NSCLC:%20Topic:%20Medical%20Oncology&rft.jtitle=Journal%20of%20thoracic%20oncology&rft.au=Rybkin,%20Igor%20I.&rft.date=2016-11&rft.volume=11&rft.issue=11&rft.spage=S307&rft.epage=S308&rft.pages=S307-S308&rft.issn=1556-0864&rft.eissn=1556-1380&rft_id=info:doi/10.1016/j.jtho.2016.09.095&rft_dat=%3Celsevier_pubme%3ES1556086416310449%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/27969527&rft_els_id=S1556086416310449&rfr_iscdi=true